Haen E, Hauck R, Emslander H P, Langenmayer I, Liebl B, Schopohl J, Remien J, Fruhmann G
Walther-Straub-Institut für Pharmakologie und Toxikologie Ludwig-Maximilians-Universität, Munich, Germany.
Chest. 1991 Nov;100(5):1239-45. doi: 10.1378/chest.100.5.1239.
To evaluate pathophysiologic mechanisms of the predominantly nocturnal complaints in atopic bronchial asthma, the expression and function of beta 2-adrenoceptors on peripheral mononuclear leukocytes (pMNL), the cAMP--as well as the cortisol--plasma concentrations were studied in eight healthy men and ten so far untreated male asthmatic patients at 4-h intervals for 24 h. No difference was seen in the beta 2-adrenoceptor density (Bmax) on pMNL between healthy and asthmatic men (24-h means +/- SE: 908 +/- 59 sites per cell and 821 +/- 54 sites per cell, respectively). The equilibrium dissociation constant (Kd), however, was significantly higher in the asthmatic patients (24-h mean +/- SE: 8.8 +/- 1.2 pmol/L vs 3.0 +/- 0.2 pmol/L in healthy men, p less than 0.0001), which is equivalent to a lower affinity of the beta 2-adrenoceptors for the radioligand 125iodocyanopindolol. Bmax showed a statistically significant circadian variation, but Kd did not. The circadian variation in Bmax was reflected in the basal intracellular cyclic adenosine-monophosphate (cAMP) content of the cells investigated. High Kd values (equivalent to low receptor affinities) tended to be associated with small increases of the intracellular cAMP content after in vitro stimulation by 10(-7) mol/L isoprenaline (isoproterenol) (24-h mean +/- SE: 1.4 +/- 0.2 pmol/10(6) cells; r = -0.529, p = 0.05 at r = -0.549, n = 10). Plasma cAMP concentrations were found to be significantly lower in the asthmatic patients (24-h means +/- SE: 22.9 +/- 1.3 nmol/L vs 29.1 +/- 1.1 nmol/L, p less than 0.0001). Plasma cortisol concentrations were significantly higher in the asthmatic patients (24-h means +/- SE: 0.500 +/- 0.084 mumol/L vs 0.319 +/- 0.063 mumol/L). The results support the hypothesis that a lesion of the beta-adrenergic system contributes to the pathophysiology of atopic bronchial asthma. In the patients investigated in this study, such a lesion could be demonstrated in the affinity rather than in the number of beta 2-adrenoceptors expressed on peripheral cells of the immune system (pMNL). According to present-day knowledge of adrenergic effects on pMNL, such an affinity decrease of beta 2-adrenoceptors could account for overshooting immune responses. In association with other factors influencing respiratory function, it could be responsible for the predominantly nocturnal complaints in atopic bronchial asthma. Plasma cortisol concentrations did not appear to be related to the principal cause of "nocturnal asthma;" they rather reflected an endogenous defense mechanism to the disease.
为评估特应性支气管哮喘以夜间症状为主的病理生理机制,对8名健康男性和10名未经治疗的男性哮喘患者每4小时进行一次研究,持续24小时,观察外周血单核白细胞(pMNL)上β2 - 肾上腺素能受体的表达和功能、细胞内环磷酸腺苷(cAMP)以及血浆皮质醇浓度。健康男性与哮喘男性pMNL上β2 - 肾上腺素能受体密度(Bmax)无差异(24小时均值±标准误:分别为每细胞908±59个位点和每细胞821±54个位点)。然而,哮喘患者的平衡解离常数(Kd)显著更高(24小时均值±标准误:8.8±1.2 pmol/L,健康男性为3.0±0.2 pmol/L,p<0.0001),这相当于β2 - 肾上腺素能受体对放射性配体125碘氰吲哚洛尔的亲和力较低。Bmax有统计学意义的昼夜变化,但Kd没有。Bmax的昼夜变化反映在所研究细胞的基础细胞内环磷酸腺苷(cAMP)含量中。高Kd值(相当于低受体亲和力)往往与10⁻⁷mol/L异丙肾上腺素(异丙基肾上腺素)体外刺激后细胞内cAMP含量的小幅增加相关(24小时均值±标准误:1.4±0.2 pmol/10⁶细胞;r = -0.529,r = -0.549时p = 0.05,n = 10)。发现哮喘患者血浆cAMP浓度显著更低(24小时均值±标准误:22.9±1.3 nmol/L,健康男性为29.1±1.1 nmol/L,p<0.0001)。哮喘患者血浆皮质醇浓度显著更高(24小时均值±标准误:0.500±0.084 μmol/L,健康男性为0.319±0.063 μmol/L)。结果支持β - 肾上腺素能系统损伤促成特应性支气管哮喘病理生理的假说。在本研究的患者中,这种损伤可在免疫系统外周细胞(pMNL)上表达的β2 - 肾上腺素能受体的亲和力而非数量上得到证实。根据目前对肾上腺素能对pMNL作用的认识,β2 - 肾上腺素能受体的这种亲和力降低可能解释过度的免疫反应。与影响呼吸功能的其他因素相关,它可能是特应性支气管哮喘以夜间症状为主的原因。血浆皮质醇浓度似乎与“夜间哮喘”的主要病因无关;它们更反映了机体对该疾病的一种内源性防御机制。